A Homozygous SLC39A8 p.Asn369Thr Variant in an Infant With Leigh‐Like Encephalopathy
Case Reports in Genetics · 2026-01 · 2026 (1)
DOI: 10.1155/crig/4037228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Genetics, online erschienen am 15.11.2026. Verfasst von Muhammad Nasheet Sagri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics & Child Health Aga Khan University Karachi Pakistan aku.edu. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background Biallelic variants of SLC39A8 cause congenital disorders of glycosylation Type IIn (CDG‐IIn, OMIM #616721), a rare autosomal recessive condition characterized by impaired manganese (Mn) transport, defective glycosylation, and secondary mitochondrial dysfunction. Affected infants present with developmental delays, hypotonia, seizures, and symmetric basal ganglia lesions on brain MRI. Case Presentation An 11‐month‐old girl, previously developmentally appropriate, presented with new‐onset seizures and regression of motor and social milestones. Examination revealed global hypotonia, poor feeding, and faltered growth. Brain MRI demonstrated bilateral, symmetric T2/FLAIR hyperintensities with restricted diffusion in the caudate nuclei, putamin, globi pallidi, subthalamic nuclei, and cerebral peduncles, with sparing of the dentate nuclei and no contrast enhancement. Whole exome sequencing identified a novel homozygous SLC39A8 variant, NM_001,135,146.2:c.1106A > C (p.Asn369Thr). Each parent was a heterozygous carrier, confirming autosomal recessive inheritance. This variant is absent from ClinVar and gnomAD and is currently classified as a variant of uncertain significance (VUS). The clinical phenotype and neuroimaging pattern are compatible with SLC39A8‐CDG; however, the identified variant remains a VUS, and biochemical confirmation could not be obtained because the relevant tests were unavailable. Confirmation would require functional studies. Supportive testing would include transferrin glycosylation analysis and blood manganese measurement; a normal conventional transferrin result alone would not exclude the diagnosis. If SLC39A8‐CDG is confirmed, manganese and galactose supplementation should be considered only under specialist metabolic supervision with appropriate biochemical monitoring. This case suggests a possible phenotype‐genotype association but does not establish the pathogenicity of p.Asn369Thr.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics & Child Health Aga Khan University Karachi Pakistan aku.edu.
ORCID-Profile: Muhammad Nasheet Sagri, Abida Akbar, Bushra Rehman, Salman Kirmani
Zitieren
APA
Sagri, M. N., Akbar, A., Rehman, B., Hasan, Z., Kirmani, S., & Muhktiar, K. (2026). A Homozygous SLC39A8 p.Asn369Thr Variant in an Infant With Leigh‐Like Encephalopathy. Case Reports in Genetics, 2026(1). https://doi.org/10.1155/crig/4037228
Vancouver
Sagri MN, Akbar A, Rehman B, Hasan Z, Kirmani S, Muhktiar K. A Homozygous SLC39A8 p.Asn369Thr Variant in an Infant With Leigh‐Like Encephalopathy. Case Reports in Genetics. 2026;2026(1). doi:10.1155/crig/4037228
BibTeX
@article{Sagri2026,
author = {Sagri, Muhammad Nasheet and Akbar, Abida and Rehman, Bushra and Hasan, Zohra and Kirmani, Salman and Muhktiar, Khairunnisa},
title = {A Homozygous SLC39A8 p.Asn369Thr Variant in an Infant With Leigh‐Like Encephalopathy},
journal = {Case Reports in Genetics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crig/4037228}
}
EUVIMED